The National Comprehensive Cancer Network® Supports SBRT for Prostate Cancer

The National Comprehensive Cancer Network recently updated their patient guide that supports stereotactic body radiation therapy (SBRT) for prostate cancer. 

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 26 of the world’s leading cancer centers, is dedicated to improving the quality, efficiency, and effectiveness of care for patients with cancer.  

NCCN aims to provide people with cancer and the general public with state-of-the-art cancer treatment information in easy-to-understand language.  The NCCN Guidelines for Patients®, translations of the NCCN clinical guidelines, are meant to help patients with cancer talk with their physicians about the best treatment options for their disease. 

The NCCN guidelines for patients now states “Stereotactic body radiotherapy (SBRT, for short) has been added as an option to be carefully decided.  If chosen, it should be received at cancer centers with the proper equipment and experience.” 

At Columbus CyberKnife, our physician team and staff have extensive experience treating patients with stereotactic radiation therapy.  Prostate cancer patients are treated with SBRT using the CyberKnife® Robotic Radiosurgery System.  CyberKnife is a powerful, noninvasive treatment system that precisely focuses radiation to match the size and shape of a patient’s prostate cancer, minimizing damage to surrounding tissue. 

For more information on NCCN’s Guidelines for Patients, please click here.  To learn more about the benefits of CyberKnife treatment, or to find out if you are a candidate, click here.

Columbus CyberKnife Celebrates Five-Year Anniversary

This month, Columbus CyberKnife honors five years of cancer care since opening on the campus of hospital partner Mount Carmel St. Ann’s Hospital.

Over the past five years, our physicians and staff have worked to connect with the community and spread awareness of CyberKnife® treatment among patients in Ohio and beyond. Below are a few milestones we are proud to recognize:

  • Columbus CyberKnife’s clinical team has treated more than one thousand patients. As the only CyberKnife treatment provider in the area, we have specialized expertise in our most frequently treated diseases, which include brain tumors and lung and prostate cancers. 
  • The CyberKnife technology used to treat patients at our center was upgraded last year. The next-generation CyberKnife system includes Lung Optimization Treatment (LOT), which expands treatment capabilities for high-risk lung cancer patients.
  • As a medical device that provides a specialized type of radiation therapy, CyberKnife reached a 20-year milestone since the first prototype was developed and used at Stanford in the mid-90s. The inclusion of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy in the model policies and guidelines of national organizations, such as the American Society for Radiation Oncology (ASTRO), the National Comprehensive Cancer Network (NCCN) and the American College of Radiology have added to a growing base of support and long-term clinical evidence for the treatment. In turn, Columbus CyberKnife has seen growing support from physicians to refer patients for CyberKnife SRS and SBRT.

We are proud to have the opportunity to continue serving cancer patients throughout the region. If you or a loved one would like to learn more about CyberKnife treatment, please contact our center.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Research Shows Stereotactic Radiosurgery for Metastatic Brain Tumors Improves Survival Rates for Patients Under 50

In a recent study published in the journal of the American Society for Radiation Oncology (ASTRO), researchers demonstrated the efficacy of stereotactic radiosurgery (SRS) in the treatment of brain metastases, or tumors that have spread from a primary tumor in another area of the body to the brain.

The study examined the survival rates of patients age 50 and younger who received only SRS in comparison to patients of the same age group who received both SRS and whole brain radiation therapy (WBRT). Researchers determined that the survival rate was improved by 13 percent for patients who received SRS alone, when compared to the other group. To read more details from the study, click here.

Columbus CyberKnife uses advanced CyberKnife® technology to treat brain metastases with SRS. CyberKnife treats tumors in the brain with highly focused radiation, while sparing healthy surrounding tissue. CyberKnife SRS offers brain tumor patients an aggressive treatment option with minimal disruption to normal activities. Typically, patients experience few to no side effects from treatment, which does not require surgery or sedation.

To find out if you or a loved one could be a candidate for CyberKnife treatment, contact our center.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Men’s Health Week: Prostate Cancer and Second Opinions

June 15 – 21 is honored as Men’s Health Week, dedicated to raising awareness for all aspects of men’s health.

At Columbus CyberKnife, we work to educate our patients on the importance of seeking a second opinion. When developing treatment plans, we consult specialists from various areas of cancer care to offer a well-rounded approach. As a patient, it’s important that men ask questions and seek guidance from a variety of trusted professionals to help make an informed treatment decision. This is particularly important when facing a prostate cancer diagnosis.

Following a prostate cancer diagnosis, you may be presented a few different treatment options. As you learn more about each option, consider consulting the perspective of a radiation oncologist before deciding on a treatment plan.

Meeting with a physician who specializes in the treatment of cancer with radiation, such as a radiation oncologist, is an important step in feeling educated about the advantages and disadvantages of each method. Take time to ask questions that will help you understand how different treatments can affect you in the short and long term.

Columbus CyberKnife’s experienced team considers factors such as your medical and family history, current health, diagnosis and personal needs, before recommending options for an overall treatment plan. If you or a loved one has been diagnosed with prostate cancer and would like a second opinion, call our center at (614) 898-8300.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Metastatic Lung Cancer: CyberKnife Treatment Effective According to Recent Study

In a recent study examining the efficacy of CyberKnife® for the treatment of lung cancer metastases, researchers determined that patients may experience better local control and low toxicity.

The study results were drawn from a retrospective analysis of 95 patients with 134 lung metastases treated with CyberKnife stereotactic body radiation therapy (SBRT). This treatment method precisely targets tumors with high-dose radiation that is delivered in five or fewer treatments. The approach offers an important option for patients with recurring metastatic tumors who may require a nonsurgical treatment method. Read details of the study here.

Lung cancer is among the most common metastatic cancers. If diagnosed at a later stage, the cancer is likely to have spread, or metastasized. Common sites of lung cancer metastasis include the lymph nodes, the brain and bones.

At Columbus CyberKnife, lung cancer and metastatic tumors are frequently treated conditions. To learn more about how CyberKnife treats metastatic cancer, visit our Conditions Treated page.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

New Study Shows CyberKnife Effective for Localized Prostate Cancer

A recent prostate cancer study examined the outcomes of CyberKnife® treatment for low and immediate risk patients with early stage prostate cancer. Researchers examined the cases of 32 patients over a two-year period. After receiving CyberKnife treatment, patients experienced lower toxicity levels and fewer instances of recurrence for years following treatment.

Columbus CyberKnife treats prostate cancer patients with stereotactic body radiation therapy (SBRT) using CyberKnife technology. For early stage prostate cancer patients, this treatment method offers unique benefits that allow patients to receive treatment with minimal disruption to their daily activities.

The CyberKnife pinpoints tumors with sub-millimeter accuracy and minimizes radiation exposure to surrounding healthy tissue. CyberKnife’s advanced range of motion allows physicians to treat difficult-to-reach areas in the body. Most patients experience few to no side effects and return to their normal activities immediately following each session.

Read more about the CyberKnife study here or contact Columbus CyberKnife at (614) 898-8300 to learn about the CyberKnife treatment process for prostate cancer and whether you may be a candidate for treatment.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Patient Perspectives: ‘How Will the Treatment Affect my Daily Routine?’

At Columbus CyberKnife, a key part of our consultation and treatment process is educating our patients on what they can expect before, during and after treatment. One common question our care team hears from patients is “how will the treatment affect my daily routine?”

For some patients, maintaining a daily routine is important, particularly for those who work or travel. Fortunately, as cancer technology and approaches to treatment have advanced, there are options and methods available that can help to reduce the impact of cancer treatment on a patient’s daily routine. One example of this is stereotactic radiosurgery (SRS).

SRS is a noninvasive treatment in which precisely targeted, high-dose radiation is delivered to tumors in one to five outpatient sessions. Patients do not have to undergo surgery, sedation or a prolonged recovery time. This benefit is particularly important for patients who are seeking a treatment option that allows them to maintain their routines or continue going to work. Columbus Cyberknife delivers SRS using the CyberKnife® system.

In addition to convenience, CyberKnife SRS is also safe and effective. There is a growing base of clinical research and information available demonstrating the treatment’s effectiveness for several types of cancers, including lung cancer, prostate cancer, brain tumors and metastatic cancer.

For more information, view our post on what to expect during CyberKnife treatment

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Words From Our Patients: Prostate Cancer Treatment at Columbus CyberKnife

Columbus CyberKnife offers patients an effective and convenient cancer treatment option completed in five or fewer sessions with minimal disruption to normal activities. Watch the video below to hear about the experience of Ward, a former CyberKnife prostate cancer patient.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.

Acoustic Neuroma Awareness Week: How CyberKnife Can Help

Acoustic Neuroma Awareness Week 2015 is celebrated nationwide May 10 – 16.

According to the Acoustic Neuroma Association, acoustic neuroma is a slow-growing tumor of the nerve that connects the ear to the brain. This nerve is called the vestibular cochlear nerve and is located behind the ear, right under the brain.

Typical symptoms include hearing loss or deafness, pressure in the inner ear, impaired sense of balance and ability to walk, as well as vertigo with associated nausea and vomiting. Many patients report tinnitus, or ringing in the ear.

Acoustic neuromas can also affect the facial area, but are usually discovered before they cause facial symptoms. However, if they are large or impacting one of the facial nerves, they can cause numbness, tingling or even paralysis.

Studies show that stereotactic radiosurgery is an excellent treatment approach for patients with acoustic neuroma because the tumor is controlled approximately 95% of the time, and the risk of serious side effects is extremely low.

Our center uses CyberKnife® technology, an advanced form of radiation therapy that does not require anesthesia, incisions or a prolonged recovery time, to deliver focused radiation treatment. The underlying premise is to treat the tumor with a high dose of radiation, while sparing the nerves and brain tissues.

Contact Columbus CyberKnife today at (614) 898-8300 to find out if CyberKnife can be integrated into your acoustic neuroma treatment plan. 

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.